CDC Data: Omicron Subvariant XBB.1.16, or ‘Arcturus,’ Causing 20% of New COVID-19 Infections

Moderna this week asked the FDA to authorize its candidate for an updated coronavirus vaccine, which is expected to roll out in the fall.